Alpha Tau Medical
DRTS
16 hedge funds and large institutions have $1.87M invested in Alpha Tau Medical in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
14% more funds holding
Funds holding: 14 → 16 (+2)
10% more capital invested
Capital invested by funds: $1.7M → $1.87M (+$173K)
0.16% more ownership
Funds ownership: 0.79% → 0.94% (+0.16%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$231K |
| 2 |
PMG
ProVise Management Group
Clearwater,
Florida
|
+$122K |
| 3 |
CWM
Circle Wealth Management
Summit,
New Jersey
|
+$50.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.2K |
| 5 |
SPIA
Steward Partners Investment Advisory
New York
|
+$21.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
STA
Summit Trail Advisors
New York
|
-$32.7K |
| 2 |
JP Morgan Chase
New York
|
-$2.69K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$886 |
| 4 |
Citigroup
New York
|
-$77 |
| 5 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$33 |
DRTS Hedge Fund Activity: Q1 2023 in Review
16 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q1 2023, worth a combined $1.87M — up 10% from $1.7M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new DRTS positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was ETF Managers Group, opening a new position worth an estimated $231K. The largest seller was Summit Trail Advisors, exiting entirely with an estimated $32.7K sold.
- 16 institutional investors held Alpha Tau Medical (DRTS) as of Q1 2023, up from 14 in Q4 2022.
- Funds reported $1.87M of Alpha Tau Medical stock for Q1 2023, up 10% quarter-over-quarter.
- 4 funds opened new Alpha Tau Medical positions in Q1 2023 and 2 closed out, a net change of +2 holders.
- The largest Alpha Tau Medical buyer in Q1 2023 was ETF Managers Group, an estimated $231K added.
- The largest Alpha Tau Medical seller in Q1 2023 was Summit Trail Advisors, an estimated $32.7K sold.
Based on aggregated 13F filings for Q1 2023.